Showing results (1431-1440 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|March 24, 2022
Differences in Thickness-Specific Incidence and Factors Associated With Cutaneous Melanoma in the US From 2010 to 2018Michael L Chen, Isabella Joy de Vere Hunt, Esther M John, et al.
JAMA Oncology|March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical TrialWang-Zhong Li, Xing Lv, Dan Hu, et al.
JAMA Oncology|January 21, 2021
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical TrialDavendra P S Sohal, Mai Duong, Syed A Ahmad, et al.
JAMA Oncology|January 21, 2021
Aspirin Use and Risk of Colorectal Cancer Among Older AdultsChuan-Guo Guo, Wenjie Ma, David A Drew, et al.
JAMA Oncology|October 4, 2019
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast CancerLi Sun, Adam Brentnall, Shreeya Patel, et al.
JAMA Oncology|September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical TrialGhassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
JAMA Oncology|September 13, 2019
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With CancerDavid J Pinato, Sarah Howlett, Diego Ottaviani, et al.
JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
JAMA Oncology|February 4, 2021
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical TrialLaurence Klotz, Joseph Chin, Peter C Black, et al.
JAMA Oncology|July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.
Pageof 162